Introduction {#s001}
============

In several studies, near-infrared spectroscopy (NIRS) has been used to measure regional cerebral oxygen saturation (rSO~2~) in patients with postcardiac arrest syndrome (PCAS) to predict the outcome and analyze the brain\'s metabolic status (Meex *et al.*, [@B14]; Ahn *et al.*, [@B1]; Storm *et al.*, [@B18]; Ibrahim *et al.*, [@B11]). In these studies of PCAS patients in the intensive care unit (ICU), rSO~2~ was significantly lower in nonsurviving (Meex *et al.*, [@B14]; Ahn *et al.*, [@B1]) and poor neurological outcome patients (Storm *et al.*, [@B18]) than in surviving or good neurological outcome patients. In contrast, Ibrahim *et al.* ([@B11]) reported that there was no difference between the rSO~2~ of survivors and nonsurvivors in the ICU setting. Recently, Ihara *et al.* ([@B12]) showed that there was no difference in the rSO~2~ value between severely brain-injured PCAS patients with abnormal amplitude-integrated electroencephalography (aEEG) and mildly brain-injured patients with continuous aEEG wave. This was because the rSO~2~ of patients with abnormal aEEG had a dramatically wider range than that of patients with normal aEEG. It was concluded that this variation in rSO~2~ in patients with severe brain injury may indicate the pathophysiology of postcardiac arrest brain injury owing to impaired cerebrovascular autoregulation (CVAR) and cerebral blood flow (CBF) (Ihara *et al.*, [@B12]).

Generally, brain oxygenation, measured by rSO~2~, will depend on Fick\'s principle: rSO~2~ = SaO~2~-CMRO~2~/(1.34 × Hb × CBF) (SaO~2~: arterial oxygen saturation, CMRO~2~: cerebral oxygen metabolic ratio, Hb: hemoglobin). CMRO~2~ changes depending on the body temperature (BT) (Ehrlich *et al.*, [@B10]) and severity of whole-brain ischemic injury (Tichauer *et al.*, [@B20]). CBF is described by the Hagen-Poiseuille\'s equation: CBF = k × ((MAP-ICP) × d^4^)/(L × μ) (k: physical constant, MAP: mean arterial pressure, ICP: intracranial pressure, d: cerebral vessel diameter, μ: blood viscosity, L: length of vessel). Cerebral vessel diameter is regulated by arterial carbon dioxide pressure (PaCO~2~) and μ is influenced by Hb (Nakashima *et al.*, [@B15]). In the standard ICU setting for PCAS patients, parameters such as SaO~2~, Hb, MAP, BT, and PaCO~2~ are usually evaluated. Therefore, by investigating the relationship between rSO~2~ and these parameters, we could indirectly estimate brain oxygenation in the injured brain. This study is a *post hoc* analysis of our previous investigation (Ihara *et al.*, [@B12]) estimating the relationship between rSO~2~ and parameters such as SaO~2~, Hb, PaCO~2~, MAP, and BT.

Methods {#s002}
=======

This observational study was performed at the intensive care unit at Nihon University Itabashi Hospital. Approval was obtained from the Clinical Research Institutional Review Board (IRB) of the Nihon University School of Medicine Itabashi Hospital (RK-121109-1). Participants of this study were comatose survivors of out-of-hospital PCAS, aged 20 years or older, and treated with targeted-temperature management (TTM) from July 1, 2012 to June 31, 2015. This study included consecutive patients treated with TTM; however, patients were excluded if (1) they died abruptly within 72 hours after cardiac arrest without sufficient evaluation of brain function or (2) they had a history of neurological diseases or brain injury.

The details of the TTM protocol have been described in our previous study (Ihara *et al.*, [@B12]). In brief, patients who remained comatose after return of spontaneous circulation (ROSC) were treated with TTM at 34°C for 24 hours. After patients with ROSC were sedated (midazolam, 0.08 mg/kg intravenously) and paralyzed (rocuronium bromide, 0.8 mg/kg intravenously) to control shivering, the conditions were maintained with a continuous infusion of midazolam (0.05--0.1 mg/kg/h), fentanyl (1 μg/kg/h), and rocuronium (0.3--0.6 mg/kg/h). The parameters were measured and recorded as follows: mean blood pressure (BP) \>65 mmHg, SpO~2~ 94--97%, PaCO~2~ 35--45 mmHg, and Hb \<7 g/dL. All patients were monitored for rSO~2~ (INVOS 5100 C; Covidien, Boulder, CO) immediately after the patient\'s arrival in the ICU. The NIRS probe was placed on the left forehead to detect frontal cerebral oxygen saturation. rSO2 and the other parameters (MAP, SaO~2~, PaCO~2~, and Hb) were evaluated at the start of monitoring and 24 and 48 hours after ROSC. The neurological outcome was assessed using the Cerebral Performance Category (CPC) scale (Cummins *et al.*, [@B7]) during discharge from the hospital. Patients were divided into two groups according to the outcome: favorable neurological outcome (favorable group) was defined as patients with a CPC score of 1 or 2, and unfavorable outcome (unfavorable group) was defined as patients with a CPC score of 3--5.

Statistical analysis was performed using SPSS (IBM SPSS Version 22). The Fisher\'s exact probability test, *t* test, and Mann--Whitney U test were used to assess statistical significance of characteristics and parameters between favorable group and unfavorable group. Relationships between rSO~2~ and each parameter were examined with the Spearman\'s rank correlation coefficient and multiple regression analysis. A *p*-value \<0.05 was considered statistically significant.

The ratio of variation to mean value at rSO~2~ and each parameter between favorable groups was evaluated by the coefficient of variation (CV = \[standard deviation/mean\] × 100). The significant difference in CV between the two groups was calculated using the likelihood ratio test with the hypothesis that k normally distributed populations share the same CV. The web program that we used to statistically analyze CV is [www1.fpl.fs.fed.us/covtestk.html](www1.fpl.fs.fed.us/covtestk.html). This method was mentioned in a previous study (Ihara *et al.*, [@B12]). A *p*-value \<0.05 was also considered statistically significant.

Results {#s003}
=======

The details of patients flow has been described in detail in our previous study (Ihara *et al.*, [@B12]). In addition, 2 patients died within 72 hours during TTM and they were excluded in the subsequent studies and analysis as was the case in the previous study (Ihara *et al.*, [@B12]). Forty-nine patients were included in this study, with 15 patients in the favorable group (CPC1: 11 cases, CPC2: 4) and 34 in the unfavorable group (CPC3: 3, CPC4: 11, CPC5: 20). Patient characteristics are presented in [Table 1](#tb1){ref-type="table"}. There were significant differences between the favorable and unfavorable groups with respect to gender male (80% vs. 50%), proportion with shockable rhythm (60% vs 27%), and time from arrest to ROSC (20.9 ± 19.1 vs. 36.4 ± 18.2; minutes). The rSO~2~ value was compared between the two groups, and there was no significant difference at any time point. Hb was significantly larger in the favorable group compared to the unfavorable group at every time point, as was MAP at the start of monitoring and at 24 hours ([Table 2](#tb2){ref-type="table"}).

###### 

Comparison of Characteristics Between Patients in the Favorable and Unfavorable Groups

                                                         Favorable group*n* = 15   Unfavorable group*n* = 34   *p* value
  ------------------------------------------------------ ------------------------- --------------------------- -----------
  Age, years, mean ± SD                                  57.8 ± 18.2               67.7 ± 14.2                 0.068
  Male, *n* (%)                                          12 (80)                   17 (50)                     0.049
  Cardiac cause, *n* (%)                                 10 (67)                   18 (53)                     0.371
  Witnessed, *n* (%)                                     13 (87)                   24 (71)                     0.228
  Shockable rhythm, *n* (%)                              9 (60)                    9 (27)                      0.025
  Bystander CPR, *n* (%)                                 10 (67)                   15 (42)                     0.146
  Time from arrest to ROSC, min, mean ± SD               20.9 ± 19.1               36.4 ± 18.2                 0.010
  Time from ROSC to rSO~2~ application, min, mean ± SD   351.9 ± 199.4             350.6 ± 177.5               0.845

CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation; rSO~2~, regional cerebral oxygen saturation.

###### 

Comparing of Patient Parameters Between the Favorable and Unfavorable Groups for Every Time Point

                           Favorable group*n* = 15   Unfavorable group*n* = 34   *p* value
  ------------------------ ------------------------- --------------------------- -----------
  Start of monitoring                                                            
   rSO~2~ (%)              55.5 ± 5.9                57.1 ± 14.0                 0.587
   SaO~2~ (%)              97.5 ± 2.0                97.1 ± 2.5                  0.494
   Hb (g/dL)               14.4 ± 2.8                12.1 ± 2.9                  0.008
   PaCO~2~ (mmHg)          34.9 ± 6.7                35.1 ± 7.8                  0.803
   MAP (mmHg)              101.2 ± 18.4              87.1 ± 16.6                 0.015
   Body temperature (°C)   34.3 ± 0.8                33.9 ± 0.6                  0.112
  After 24 hours                                                                 
   rSO~2~ (%)              62.9 ± 9.1                57.6 ± 15.8                 0.615
   SaO~2~ (%)              96.4 ± 3.0                97.0 ± 2.1                  0.730
   Hb (g/dL)               13.7 ± 3.3                11.7 ± 2.7                  0.039
   PaCO~2~ (mmHg)          36.5 ± 6.1                36.6 ± 9.4                  0.879
   MAP (mmHg)              104.3 ± 15.9              85.9 ± 18.2                 0.001
   Body temperature (°C)   34.5 ± 1.0                34.3 ± 1.0                  0.806
  After 48 hours                                                                 
   rSO~2~ (%)              68.9 ± 10.9               64.5 ± 13.3                 0.275
   SaO~2~ (%)              96.3 ± 2.2                96.1 ± 3.3                  0.654
   Hb (g/dL)               13.4 ± 3.1                10.8 ± 2.3                  0.012
   PaCO~2~ (mmHg)          40.0 ± 6.1                37.4 ± 6.9                  0.341
   MAP (mmHg)              97.5 ± 20.4               85.9 ± 23.0                 0.123
   Body temperature (°C)   36.3 ± 0.8                35.9 ± 0.8                  0.076

Mean ± SD.

rSO~2~, regional cerebral oxygen saturation; SaO~2~, arterial oxygen saturation; Hb, hemoglobin; PaCO~2~, arterial carbon dioxide pressure; MAP, mean arterial pressure.

The CV of the rSO~2~ in the unfavorable group was significantly greater than that in the favorable group at the start of monitoring \[CV: unfavorable (24.5) vs. favorable (10.6), *p* = 0.0015\] and at 24 hours (27.4 vs. 14.5, *p* = 0.0108) after ROSC. In contrast, there were no significant differences in the CV of rSO~2~ at 48 hours and SaO~2~, Hb, PaCO~2~, MAP, or BT at any time point between the two groups.

The correlation coefficient between rSO~2~ and each parameter at every time point is given in [Table 3](#tb3){ref-type="table"} for both groups. [Table 4](#tb4){ref-type="table"} shows the results of the multiple regression analysis between rSO~2~ and each parameter at every time point in the favorable and unfavorable group. In the favorable group, SaO~2~, Hb, and PaCO~2~ had moderate correlations with rSO~2~ at 24 hours, and the standardized partial regression coefficients were 0.482, 0.422, and 0.531, respectively. In the unfavorable group, rSO~2~ was moderately correlated with Hb at all time points, PaCO~2~ at 24 hours and MAP at 24 and 48 hours.

###### 

Correlation Coefficient Between rSO~2~ and Each Parameter at Every Time Point in the Favorable and Unfavorable Groups

                        SaO~2~   Hb          PaCO~2~     MAP         BT
  --------------------- -------- ----------- ----------- ----------- --------
  Start of monitoring                                                
   Favorable group      −0.397   0.667^\*^   0.653^\*^   0.428       0.742
   Unfavorable group    0.329    0.488^\*^   −0.131      0.013       0.107
  24 hours after ROSC                                                
   Favorable group      0.409    0.697^\*^   0.460       0.421       −0.110
   Unfavorable group    −0.026   0.524^\*^   0.259       0.558^\*^   0.088
  48 hours after ROSC                                                
   Favorable group      −0.056   0.621^\*^   0.558       0.435       −0.080
   Unfavorable group    −0.102   0.622^\*^   0.276       0.529^\*^   0.485

Correlation coefficient; ^\*^ρ \< 0.05.

rSO~2~, regional cerebral oxygen saturation; ROSC, return of spontaneous circulation; SaO~2~, arterial oxygen saturation; Hb, hemoglobin; PaCO~2~: arterial carbon dioxide pressure; MAP, mean arterial pressure.

###### 

Multiple Regression Analysis Between rSO~2~ and Each Parameter at Every Time Point in the Favorable and Unfavorable Groups

                        SaO~2~      Hb          PaCO~2~     MAP         BT       R^2^
  --------------------- ----------- ----------- ----------- ----------- -------- -------
  Start of monitoring                                                            
   Favorable group      0.119       0.345       0.356       0.123       0.222    0.485
   Unfavorable group    0.269       0.579^\*^   0.023       −0.150      0.078    0.424
  24 hours after ROSC                                                            
   Favorable group      0.482^\*^   0.422^\*^   0.531^\*^   0.004       −0.031   0.911
   Unfavorable group    0.124       0.555^\*^   0.269^\*^   0.328^\*^   0.223    0.526
  48 hours after ROSC                                                            
   Favorable group      0.669       0.559       1.052       −0.336      0.003    0.758
   Unfavorable group    0.037       0.550^\*^   0.205       0.408^\*^   0.111    0.647

Standardized partial regression coefficients; ^\*^ρ \< 0.05.

rSO~2~, regional cerebral oxygen saturation; ROSC, return of spontaneous circulation; SaO~2~, arterial oxygen saturation; Hb, hemoglobin; PaCO~2~, arterial carbon dioxide pressure; MAP, mean arterial pressure; BT, body temperature.

Discussion {#s004}
==========

In the present study, there was no significant difference in rSO~2~ values between the two groups at any time point after resuscitation from CA. The value of rSO~2~ in the unfavorable group had a significantly larger variation than that in the favorable group in early stages after ROSC, although there were no significant differences in the variation of the other parameters between the two groups. In the favorable group, SaO~2~, Hb, and PaCO~2~ had moderate correlations with rSO~2~ only at 24 hours. In the unfavorable group, moderate correlations existed between rSO~2~ and Hb at all time points, PaCO~2~ at 24 hours, and MAP at 24 and 48 hours.

In theory, the concentration of Hb must have a binary effect on brain oxygenation. According to Fick\'s principle, as Hb concentration increases, brain oxygenation will also increase because of the increase in oxygen carrier. On the contrary, based on Hagen--Poiseuille\'s law, as Hb concentration increases, brain oxygen will decrease as CBF decreases with augmented blood viscosity owing to Hb. However, practically, the relationship between rSO~2~ and Hb concentration obeys Fick\'s principle, with rSO~2~ having a positive correlation with Hb concentration in cardiac surgical and neurosurgical patients (Yoshitani *et al.*, [@B21]). In the present study, Hb concentration was significantly positively correlated with rSO~2~ at all time points in the unfavorable group and at 24 hours in the favorable group. This indicates that brain oxygenation based on Hb concentration obeys Fick\'s principle. Storm *et al.* reported that rSO~2~ was significantly lower in patients with poor outcomes; however, Hb concentration was also significantly lower in those patients (Storm *et al.*, [@B18]). As they pointed out in their discussion, low rSO~2~ in their study may be due to a low Hb concentration, rather than the severity of brain injury.

In an experimental study of piglets with hypoxia-ischemia, CMRO~2~ decreased after resuscitation (Tichauer *et al.*, [@B20]). Clinically, Edgren *et al.* ([@B8]) using positron emission tomography study reported that the initial CMRO~2~ of PCAS patients was commonly low, irrespective of whether their outcome was favorable or not. CMRO~2~ depends on body temperature and decreases during hypothermia (Ehrlich *et al.*, [@B10]), and there was no difference in body temperature between the favorable and unfavorable groups in the present study. Therefore, low CMRO~2~ may not influence the difference in rSO~2~ between groups.

It was reported that in the majority of PCAS patients in their acute phase after cardiac arrest, the CVAR and CBF were either absent or right shifted (Sundgreen *et al.*, [@B19]). In addition, during the evaluation of rSO~2~ for PCAS patients after ROSC, the impairment of CVAR following CA is associated with poor outcome (Brady *et al.*, [@B5]; Ameloot *et al.*, [@B2]; Pham *et al.*, [@B16]). If CVAR is sustained because of mild brain injury in PCAS patients, rSO~2~ may not change depending on MAP and may change on SaO~2~, Hb, and PaCO~2~ as per the Fick\'s principle. In this study rSO~2~ moderately correlated with SaO~2~, Hb, and PaCO~2~ and had no correlation with MAP in the favorable group at 24 hours. It indicates that the favorable group may have mild brain injury and CVAR is sustained. Conversely, if PCAS patients with severe brain injury are completely impaired in CVAR and CBF, rSO~2~ and MAP may not be positively correlated. This pattern might explain the patient\'s situation of the unfavorable group at the start of monitoring. If CVAR is right-shifted, change in CBF depending on MAP and rSO~2~ may positively correlate with MAP. This was observed in patients of the unfavorable group at 24 and 48 hours after ROSC. Ihara *et al.* ([@B12]) reported that the CV of rSO~2~ in PCAS patients with abnormal EEG was significantly larger than those with normal EEG and suggested that it resulted in an impaired CVAR. This hypothesis may not contraindicate the results of this study. Patients with unfavorable outcome should have severe brain injury and the impairment of CVAR. It may indicate wide variation of CBF and wide variation of rSO~2~ in patients of unfavorable group, compared with those of favorable group. There is no standard value of MAP that would be appropriate for all hemodynamic targets (Ameloot *et al.*, [@B2]). Due to an impaired CVAR, we could control MAP by measuring rSO~2~ to avoid brain ischemia for PCAS management (Sekhon *et al.*, [@B17]).

The cerebral vasculature constricts by decreasing PaCO~2~, and this CO~2~ reactivity results in a reduction of CBF (Kontos *et al.*, [@B13]). If CO~2~ reactivity is preserved without brain damage, then rSO~2~ and PaCO~2~ are positively correlated (Booth *et al.*, [@B4]). In the present study, rSO~2~ and PaCO~2~ were positively correlated in the favorable and unfavorable groups, which suggests that the reactivity of PaCO~2~ was preserved in these patients. On the contrary, there was no significant correlation between rSO~2~ and PaCO~2~ in other conditions. In PCAS patients, CO~2~ reactivity was reported to be preserved, although they had severe brain injury owing to CA (Buunk *et al.*, [@B6]; Bisschops *et al.*, [@B3]). As mentioned above, CVAR is impaired in certain brain injuries by CA, and CBF may change depending on MAP. In such a situation, we may not evaluate PaCO~2~ reactivity by this method. We need to measure the response of rSO~2~ value individually in PCAS patients, thus changing PaCO~2~ by controlling the ventilator.

This study, however, has its limitations. If rSO~2~ is measured in patients with a normal or mildly injured brain, rSO~2~ should be correlated with SaO~2~, Hb, and PaCO~2~ and not with MAP. This could explain Fick\'s formula (Nakashima *et al.*, [@B15]) and display normal CVAR (Sundgreen *et al.*, [@B19]; Brady *et al.*, [@B5]; Pham *et al.*, [@B16]). In this study, only patients in the favorable group at 24 hours were followed with this hypothesis. Although we could not explain this phenomenon exactly, it may be due to the following reasons: (1) the number of patients may be too small; (2) each parameter was managed within a narrow range, causing the variation range to be narrow; and (3) an unstable brain situation immediately after resuscitation at the start of monitoring and due to change in brain metabolism during the rewarming stage at 48 hours.

Pham *et al.* ([@B16]) reported that early impairment of CVAR following cardiac arrest is independently associated with mortality. Our results suggest that rSO~2~ was moderately correlated with MAP and CVAR and could be impaired in PCAS patients with unfavorable outcome. Ehara *et al*. ([@B9]) showed that in the unfavorable patients, the cerebral rSO~2~ values increased significantly just after the start of ECPR. Taken together, we could predict the outcome for PCAS patients at a very early stage of ROSC by evaluating the relationship between rSO~2~ and blood pressure. Ameloot *et al.* ([@B2]) suggested that there is no "one-size-fits-all" hemodynamic target for the PCAS patients because of impaired CVAR. In this study, rSO2 was changed by MAP, SaO~2~, Hb, and PaCO~2~, depending on patient\'s brain severity. By evaluation of rSO~2~ in PCAS patients, we could optimize brain oxygen metabolic balance through management of the parameters influencing brain oxygenation such as SaO~2~, Hb, MAP, and PaCO~2~.

Conclusion {#s005}
==========

In this study, variation of rSO~2~ was widely dependent on MAP in unfavorable patients, maybe because of impaired CVAR. It will be difficult to predict the outcome by absolute values of rSO~2~ in the case of PCAS patients. To evaluate brain injury in those patients by rSO~2~, we should focus on the relationship between rSO~2~ and blood pressure. Furthermore, in the management of PCAS patients with TTM by rSO~2~, we would suggest total evaluation for each parameter of SaO~2~, Hb, MAP, and PaCO~2~ to optimize brain oxygen metabolic balance.
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